Clinical Trial Update: Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 efficacy study evaluating VIMOVO (naproxen/esomeprazole) twice daily and Celebrex (celecoxib) once daily for osteoarthritis has completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• CELEBREX (Celecoxib)
• VIMOVO (naproxen/esomeprazole)

Snippet

Sponsor: POZEN | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-02-27